MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Voice harmonic amplitude differences before and after LSVT LOUDTM in Parkinson’s disease

M.P. Cannito, L.O. Ramig, A.E. Halpern, J.L. Spielman (Lafayette, LA, USA)

Meeting: 2016 International Congress

Abstract Number: 1905

Keywords: Dysarthria, Neurobehavioral disorders, Parkin

Session Information

Date: Thursday, June 23, 2016

Session Title: Parkinson's disease: Clinical trials, pharmacology and treatment

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To evaluate voice harmonic amplitudes from acoustic spectra of speech produced by subjects with Parkinson’s disease (PD) before and after voice treatment, in order to quantify voice change associated with behavioral voice treatment.

Background: Differences in harmonic amplitudes found at H1, H2, and at harmonics located at the third formant frequency (HF3) have been shown to be significant acoustic indicators of voice quality in normal and disordered speakers.

Methods: This retrospective study employed two existing data sets (Halpern et al, 2012; Cannito et al, 2012) to examine harmonic amplitude differences (HADs) in acoustic spectra of vowels produced by speakers with PD before and after voice treatment targeting increased vocal loudness, specifically LSVT LOUDTM. Halpern et al’s data set included 16 speakers with Parkinson’s disease before and after LSVT®, as supplemented with the LSVT® CompanionTM system. An immediate treatment onset group was compared with a delayed treatment onset control group. Cannito et al’s data set examined 8 speakers with PD before and after LSVT LOUD and demonstrated significant pre-to-post treatment changes in H1-H2 and H1-F3.

Results: Overall dB levels increased from pre-to-post treatment for both groups of patients. HADs (H1-H2, H1-F3) did not differ between treatment groups in the pre-treatment condition. HADs decreased significantly from pre-to-post treatment, and remained so at follow up, for both treatment groups. There was no significant interaction of treatment condition with specific vowels for either harmonic amplitude difference measure. Post-treatment changes in H1-F3 were associated with a general upward redistribution of vowel spectral energy (decreased spectral tilt) that is indicative of increased glottal closure and improved periodicity of vocal fold vibration. Cannito et al’s data set included sentence intelligibility data from a rigorously controlled listening study. Change in sentence intelligibility was found to be significantly correlated with change in harmonic amplitude difference for H1-F3, r = -.845 (r2 = .714).

Conclusions: Results indicate that as spectral tilt decreased, sentence intelligibility increased. Such changes have significant implications for both improved voice quality and speech intelligibility following voice treatment.

Portions of this research were presented at the 2014 Conference on Motor Speech and the 2012 ASHA Convention.

To cite this abstract in AMA style:

M.P. Cannito, L.O. Ramig, A.E. Halpern, J.L. Spielman. Voice harmonic amplitude differences before and after LSVT LOUDTM in Parkinson’s disease [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/voice-harmonic-amplitude-differences-before-and-after-lsvt-loudtm-in-parkinsons-disease/. Accessed May 21, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/voice-harmonic-amplitude-differences-before-and-after-lsvt-loudtm-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • The hardest symptoms that bother patients with Parkinson's disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley